Showing results (51-60 of 251) with videos related to
Sort By:
Pageof 26
Tuberculosis (Edinburgh, Scotland)|November 21, 2016
Antibodies and tuberculosisAshley J Jacobs, Juthathip Mongkolsapaya, Gavin R Screaton, et al.Tuberculosis (Edinburgh, Scotland)|August 14, 2017
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine developmentIlaria Pepponi, Bhagwati Khatri, Rachel Tanner, et al.The Lancet. Infectious Diseases|November 28, 2023
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trialAnne Wajja, Beatrice Nassanga, Agnes Natukunda, et al.Journal of Translational Medicine|November 28, 2021
A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and research collaboration networks: a bibliometric evaluation studyVasiliki Kiparoglou, Laurence A Brown, Helen McShane, et al.Plos One|June 2, 2011
Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacyAngela M Minassian, Edward O Ronan, Hazel Poyntz, et al.Frontiers in Immunology|February 28, 2025
Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosisChristopher J De Voss, Marcellus Korompis, Shuailin Li, et al.Frontiers in Immunology|May 6, 2026
Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cellsMarcellus Korompis, Christopher J De Voss, Shuailin Li, et al.Immunological Reviews|February 24, 2015
The human immune response to tuberculosis and its treatment: a view from the bloodJacqueline M Cliff, Stefan H E Kaufmann, Helen McShane, et al.The Lancet. Microbe|May 4, 2024
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection studySusan Jackson, Julia L Marshall, Andrew Mawer, et al.AIDS Research and Human Retroviruses|June 14, 2003
Tropism-restricted neutralization by secretory IgA from parotid saliva of HIV type 1-infected individualsXueling Wu, Stacy Hall, Susan JacksonPageof 26